ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hormonal Contraception Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-31G8305
Home | Market Reports | Health| Reproductive Health
Global Hormonal Contraception Market Insights Forecast to 2028
BUY CHAPTERS

Global Hormonal Contraception Market Research Report 2025

Code: QYRE-Auto-31G8305
Report
July 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Merck& Co. Inc
Pfizer Inc
Agile Therapeutics Inc
Teva Pharmaceutical Industries Ltd
Amgen Inc
Cipla Ltd
Glenmark Pharmaceuticals, Inc.
Lupin Limited(Lupin Pharmaceuticals, Inc.)
Novartis
Mylan N.V.
Johnson & Johnson
Ansell
Mayer Laboratories, Inc.

Hormonal Contraception Market

The global market for Hormonal Contraception was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Hormonal Contraception is a type of birth control that uses hormones to prevent pregnancy.
North American market for Hormonal Contraception is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Hormonal Contraception is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Hormonal Contraception include Bayer AG, Merck & Co., Inc., Pfizer, Inc., Agile Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Amgen, Cipla Ltd., Glenmark Pharmaceuticals Inc., Lupin Limited(Lupin Pharmaceuticals, Inc.), Novartis AG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hormonal Contraception, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hormonal Contraception.
The Hormonal Contraception market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hormonal Contraception market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hormonal Contraception manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hormonal Contraception Market Report

Report Metric Details
Report Name Hormonal Contraception Market
Segment by Type
  • by Hormone
  • by Method
Segment by Application
  • Hospital
  • Clinics
  • Gynaecology Centers
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer AG, Merck & Co., Inc., Pfizer, Inc., Agile Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Amgen, Cipla Ltd., Glenmark Pharmaceuticals Inc., Lupin Limited(Lupin Pharmaceuticals, Inc.), Novartis AG, Mylan N.V., Johnson & Johnson, Ansell LTD, Mayer Laboratories, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hormonal Contraception manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hormonal Contraception in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Hormonal Contraception Market report?

Ans: The main players in the Hormonal Contraception Market are Bayer AG, Merck & Co., Inc., Pfizer, Inc., Agile Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Amgen, Cipla Ltd., Glenmark Pharmaceuticals Inc., Lupin Limited(Lupin Pharmaceuticals, Inc.), Novartis AG, Mylan N.V., Johnson & Johnson, Ansell LTD, Mayer Laboratories, Inc.

What are the Application segmentation covered in the Hormonal Contraception Market report?

Ans: The Applications covered in the Hormonal Contraception Market report are Hospital, Clinics, Gynaecology Centers, Others

What are the Type segmentation covered in the Hormonal Contraception Market report?

Ans: The Types covered in the Hormonal Contraception Market report are by Hormone, by Method

1 Hormonal Contraception Market Overview
1.1 Product Definition
1.2 Hormonal Contraception by Type
1.2.1 Global Hormonal Contraception Market Value Comparison by Type (2024 VS 2031)
1.2.2 by Hormone
1.2.3 by Method
1.3 Hormonal Contraception by Application
1.3.1 Global Hormonal Contraception Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Gynaecology Centers
1.3.5 Others
1.4 Global Hormonal Contraception Market Size Estimates and Forecasts
1.4.1 Global Hormonal Contraception Revenue 2020-2031
1.4.2 Global Hormonal Contraception Sales 2020-2031
1.4.3 Global Hormonal Contraception Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hormonal Contraception Market Competition by Manufacturers
2.1 Global Hormonal Contraception Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hormonal Contraception Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hormonal Contraception Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hormonal Contraception, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hormonal Contraception, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hormonal Contraception, Product Type & Application
2.7 Global Key Manufacturers of Hormonal Contraception, Date of Enter into This Industry
2.8 Global Hormonal Contraception Market Competitive Situation and Trends
2.8.1 Global Hormonal Contraception Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hormonal Contraception Players Market Share by Revenue
2.8.3 Global Hormonal Contraception Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hormonal Contraception Market Scenario by Region
3.1 Global Hormonal Contraception Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hormonal Contraception Sales by Region: 2020-2031
3.2.1 Global Hormonal Contraception Sales by Region: 2020-2025
3.2.2 Global Hormonal Contraception Sales by Region: 2026-2031
3.3 Global Hormonal Contraception Revenue by Region: 2020-2031
3.3.1 Global Hormonal Contraception Revenue by Region: 2020-2025
3.3.2 Global Hormonal Contraception Revenue by Region: 2026-2031
3.4 North America Hormonal Contraception Market Facts & Figures by Country
3.4.1 North America Hormonal Contraception Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hormonal Contraception Sales by Country (2020-2031)
3.4.3 North America Hormonal Contraception Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hormonal Contraception Market Facts & Figures by Country
3.5.1 Europe Hormonal Contraception Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hormonal Contraception Sales by Country (2020-2031)
3.5.3 Europe Hormonal Contraception Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hormonal Contraception Market Facts & Figures by Region
3.6.1 Asia Pacific Hormonal Contraception Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hormonal Contraception Sales by Region (2020-2031)
3.6.3 Asia Pacific Hormonal Contraception Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hormonal Contraception Market Facts & Figures by Country
3.7.1 Latin America Hormonal Contraception Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hormonal Contraception Sales by Country (2020-2031)
3.7.3 Latin America Hormonal Contraception Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hormonal Contraception Market Facts & Figures by Country
3.8.1 Middle East and Africa Hormonal Contraception Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hormonal Contraception Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hormonal Contraception Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hormonal Contraception Sales by Type (2020-2031)
4.1.1 Global Hormonal Contraception Sales by Type (2020-2025)
4.1.2 Global Hormonal Contraception Sales by Type (2026-2031)
4.1.3 Global Hormonal Contraception Sales Market Share by Type (2020-2031)
4.2 Global Hormonal Contraception Revenue by Type (2020-2031)
4.2.1 Global Hormonal Contraception Revenue by Type (2020-2025)
4.2.2 Global Hormonal Contraception Revenue by Type (2026-2031)
4.2.3 Global Hormonal Contraception Revenue Market Share by Type (2020-2031)
4.3 Global Hormonal Contraception Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hormonal Contraception Sales by Application (2020-2031)
5.1.1 Global Hormonal Contraception Sales by Application (2020-2025)
5.1.2 Global Hormonal Contraception Sales by Application (2026-2031)
5.1.3 Global Hormonal Contraception Sales Market Share by Application (2020-2031)
5.2 Global Hormonal Contraception Revenue by Application (2020-2031)
5.2.1 Global Hormonal Contraception Revenue by Application (2020-2025)
5.2.2 Global Hormonal Contraception Revenue by Application (2026-2031)
5.2.3 Global Hormonal Contraception Revenue Market Share by Application (2020-2031)
5.3 Global Hormonal Contraception Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Company Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Hormonal Contraception Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer AG Hormonal Contraception Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 Merck & Co., Inc.
6.2.1 Merck & Co., Inc. Company Information
6.2.2 Merck & Co., Inc. Description and Business Overview
6.2.3 Merck & Co., Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck & Co., Inc. Hormonal Contraception Product Portfolio
6.2.5 Merck & Co., Inc. Recent Developments/Updates
6.3 Pfizer, Inc.
6.3.1 Pfizer, Inc. Company Information
6.3.2 Pfizer, Inc. Description and Business Overview
6.3.3 Pfizer, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer, Inc. Hormonal Contraception Product Portfolio
6.3.5 Pfizer, Inc. Recent Developments/Updates
6.4 Agile Therapeutics, Inc.
6.4.1 Agile Therapeutics, Inc. Company Information
6.4.2 Agile Therapeutics, Inc. Description and Business Overview
6.4.3 Agile Therapeutics, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Agile Therapeutics, Inc. Hormonal Contraception Product Portfolio
6.4.5 Agile Therapeutics, Inc. Recent Developments/Updates
6.5 Teva Pharmaceutical Industries Ltd.
6.5.1 Teva Pharmaceutical Industries Ltd. Company Information
6.5.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Ltd. Hormonal Contraception Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Pharmaceutical Industries Ltd. Hormonal Contraception Product Portfolio
6.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.6 Amgen
6.6.1 Amgen Company Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Hormonal Contraception Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Amgen Hormonal Contraception Product Portfolio
6.6.5 Amgen Recent Developments/Updates
6.7 Cipla Ltd.
6.7.1 Cipla Ltd. Company Information
6.7.2 Cipla Ltd. Description and Business Overview
6.7.3 Cipla Ltd. Hormonal Contraception Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cipla Ltd. Hormonal Contraception Product Portfolio
6.7.5 Cipla Ltd. Recent Developments/Updates
6.8 Glenmark Pharmaceuticals Inc.
6.8.1 Glenmark Pharmaceuticals Inc. Company Information
6.8.2 Glenmark Pharmaceuticals Inc. Description and Business Overview
6.8.3 Glenmark Pharmaceuticals Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Glenmark Pharmaceuticals Inc. Hormonal Contraception Product Portfolio
6.8.5 Glenmark Pharmaceuticals Inc. Recent Developments/Updates
6.9 Lupin Limited(Lupin Pharmaceuticals, Inc.)
6.9.1 Lupin Limited(Lupin Pharmaceuticals, Inc.) Company Information
6.9.2 Lupin Limited(Lupin Pharmaceuticals, Inc.) Description and Business Overview
6.9.3 Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Product Portfolio
6.9.5 Lupin Limited(Lupin Pharmaceuticals, Inc.) Recent Developments/Updates
6.10 Novartis AG
6.10.1 Novartis AG Company Information
6.10.2 Novartis AG Description and Business Overview
6.10.3 Novartis AG Hormonal Contraception Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis AG Hormonal Contraception Product Portfolio
6.10.5 Novartis AG Recent Developments/Updates
6.11 Mylan N.V.
6.11.1 Mylan N.V. Company Information
6.11.2 Mylan N.V. Description and Business Overview
6.11.3 Mylan N.V. Hormonal Contraception Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Mylan N.V. Hormonal Contraception Product Portfolio
6.11.5 Mylan N.V. Recent Developments/Updates
6.12 Johnson & Johnson
6.12.1 Johnson & Johnson Company Information
6.12.2 Johnson & Johnson Description and Business Overview
6.12.3 Johnson & Johnson Hormonal Contraception Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Johnson & Johnson Hormonal Contraception Product Portfolio
6.12.5 Johnson & Johnson Recent Developments/Updates
6.13 Ansell LTD
6.13.1 Ansell LTD Company Information
6.13.2 Ansell LTD Description and Business Overview
6.13.3 Ansell LTD Hormonal Contraception Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Ansell LTD Hormonal Contraception Product Portfolio
6.13.5 Ansell LTD Recent Developments/Updates
6.14 Mayer Laboratories, Inc.
6.14.1 Mayer Laboratories, Inc. Company Information
6.14.2 Mayer Laboratories, Inc. Description and Business Overview
6.14.3 Mayer Laboratories, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Mayer Laboratories, Inc. Hormonal Contraception Product Portfolio
6.14.5 Mayer Laboratories, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hormonal Contraception Industry Chain Analysis
7.2 Hormonal Contraception Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hormonal Contraception Production Mode & Process Analysis
7.4 Hormonal Contraception Sales and Marketing
7.4.1 Hormonal Contraception Sales Channels
7.4.2 Hormonal Contraception Distributors
7.5 Hormonal Contraception Customer Analysis
8 Hormonal Contraception Market Dynamics
8.1 Hormonal Contraception Industry Trends
8.2 Hormonal Contraception Market Drivers
8.3 Hormonal Contraception Market Challenges
8.4 Hormonal Contraception Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer
Merck& Co. Inc
Pfizer Inc
Agile Therapeutics Inc
Teva Pharmaceutical Industries Ltd
Amgen Inc
Cipla Ltd
Glenmark Pharmaceuticals, Inc.
Lupin Limited(Lupin Pharmaceuticals, Inc.)
Novartis
Mylan N.V.
Johnson & Johnson
Ansell
Mayer Laboratories, Inc.
List of Tables
 Table 1. Global Hormonal Contraception Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hormonal Contraception Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hormonal Contraception Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hormonal Contraception Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Hormonal Contraception Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hormonal Contraception Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hormonal Contraception Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hormonal Contraception Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hormonal Contraception, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hormonal Contraception, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hormonal Contraception, Product Type & Application
 Table 12. Global Key Manufacturers of Hormonal Contraception, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hormonal Contraception by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormonal Contraception as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hormonal Contraception Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hormonal Contraception Sales by Region (2020-2025) & (K Units)
 Table 18. Global Hormonal Contraception Sales Market Share by Region (2020-2025)
 Table 19. Global Hormonal Contraception Sales by Region (2026-2031) & (K Units)
 Table 20. Global Hormonal Contraception Sales Market Share by Region (2026-2031)
 Table 21. Global Hormonal Contraception Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hormonal Contraception Revenue Market Share by Region (2020-2025)
 Table 23. Global Hormonal Contraception Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hormonal Contraception Revenue Market Share by Region (2026-2031)
 Table 25. North America Hormonal Contraception Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hormonal Contraception Sales by Country (2020-2025) & (K Units)
 Table 27. North America Hormonal Contraception Sales by Country (2026-2031) & (K Units)
 Table 28. North America Hormonal Contraception Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hormonal Contraception Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hormonal Contraception Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hormonal Contraception Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Hormonal Contraception Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Hormonal Contraception Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hormonal Contraception Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hormonal Contraception Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hormonal Contraception Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Hormonal Contraception Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Hormonal Contraception Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hormonal Contraception Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hormonal Contraception Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hormonal Contraception Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Hormonal Contraception Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Hormonal Contraception Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hormonal Contraception Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hormonal Contraception Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hormonal Contraception Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Hormonal Contraception Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Hormonal Contraception Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hormonal Contraception Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hormonal Contraception Sales (K Units) by Type (2020-2025)
 Table 51. Global Hormonal Contraception Sales (K Units) by Type (2026-2031)
 Table 52. Global Hormonal Contraception Sales Market Share by Type (2020-2025)
 Table 53. Global Hormonal Contraception Sales Market Share by Type (2026-2031)
 Table 54. Global Hormonal Contraception Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hormonal Contraception Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hormonal Contraception Revenue Market Share by Type (2020-2025)
 Table 57. Global Hormonal Contraception Revenue Market Share by Type (2026-2031)
 Table 58. Global Hormonal Contraception Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Hormonal Contraception Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Hormonal Contraception Sales (K Units) by Application (2020-2025)
 Table 61. Global Hormonal Contraception Sales (K Units) by Application (2026-2031)
 Table 62. Global Hormonal Contraception Sales Market Share by Application (2020-2025)
 Table 63. Global Hormonal Contraception Sales Market Share by Application (2026-2031)
 Table 64. Global Hormonal Contraception Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hormonal Contraception Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hormonal Contraception Revenue Market Share by Application (2020-2025)
 Table 67. Global Hormonal Contraception Revenue Market Share by Application (2026-2031)
 Table 68. Global Hormonal Contraception Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Hormonal Contraception Price (US$/Unit) by Application (2026-2031)
 Table 70. Bayer AG Company Information
 Table 71. Bayer AG Description and Business Overview
 Table 72. Bayer AG Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bayer AG Hormonal Contraception Product
 Table 74. Bayer AG Recent Developments/Updates
 Table 75. Merck & Co., Inc. Company Information
 Table 76. Merck & Co., Inc. Description and Business Overview
 Table 77. Merck & Co., Inc. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Merck & Co., Inc. Hormonal Contraception Product
 Table 79. Merck & Co., Inc. Recent Developments/Updates
 Table 80. Pfizer, Inc. Company Information
 Table 81. Pfizer, Inc. Description and Business Overview
 Table 82. Pfizer, Inc. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer, Inc. Hormonal Contraception Product
 Table 84. Pfizer, Inc. Recent Developments/Updates
 Table 85. Agile Therapeutics, Inc. Company Information
 Table 86. Agile Therapeutics, Inc. Description and Business Overview
 Table 87. Agile Therapeutics, Inc. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Agile Therapeutics, Inc. Hormonal Contraception Product
 Table 89. Agile Therapeutics, Inc. Recent Developments/Updates
 Table 90. Teva Pharmaceutical Industries Ltd. Company Information
 Table 91. Teva Pharmaceutical Industries Ltd. Description and Business Overview
 Table 92. Teva Pharmaceutical Industries Ltd. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teva Pharmaceutical Industries Ltd. Hormonal Contraception Product
 Table 94. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
 Table 95. Amgen Company Information
 Table 96. Amgen Description and Business Overview
 Table 97. Amgen Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Amgen Hormonal Contraception Product
 Table 99. Amgen Recent Developments/Updates
 Table 100. Cipla Ltd. Company Information
 Table 101. Cipla Ltd. Description and Business Overview
 Table 102. Cipla Ltd. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Cipla Ltd. Hormonal Contraception Product
 Table 104. Cipla Ltd. Recent Developments/Updates
 Table 105. Glenmark Pharmaceuticals Inc. Company Information
 Table 106. Glenmark Pharmaceuticals Inc. Description and Business Overview
 Table 107. Glenmark Pharmaceuticals Inc. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Glenmark Pharmaceuticals Inc. Hormonal Contraception Product
 Table 109. Glenmark Pharmaceuticals Inc. Recent Developments/Updates
 Table 110. Lupin Limited(Lupin Pharmaceuticals, Inc.) Company Information
 Table 111. Lupin Limited(Lupin Pharmaceuticals, Inc.) Description and Business Overview
 Table 112. Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Product
 Table 114. Lupin Limited(Lupin Pharmaceuticals, Inc.) Recent Developments/Updates
 Table 115. Novartis AG Company Information
 Table 116. Novartis AG Description and Business Overview
 Table 117. Novartis AG Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Novartis AG Hormonal Contraception Product
 Table 119. Novartis AG Recent Developments/Updates
 Table 120. Mylan N.V. Company Information
 Table 121. Mylan N.V. Description and Business Overview
 Table 122. Mylan N.V. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Mylan N.V. Hormonal Contraception Product
 Table 124. Mylan N.V. Recent Developments/Updates
 Table 125. Johnson & Johnson Company Information
 Table 126. Johnson & Johnson Description and Business Overview
 Table 127. Johnson & Johnson Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Johnson & Johnson Hormonal Contraception Product
 Table 129. Johnson & Johnson Recent Developments/Updates
 Table 130. Ansell LTD Company Information
 Table 131. Ansell LTD Description and Business Overview
 Table 132. Ansell LTD Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Ansell LTD Hormonal Contraception Product
 Table 134. Ansell LTD Recent Developments/Updates
 Table 135. Mayer Laboratories, Inc. Company Information
 Table 136. Mayer Laboratories, Inc. Description and Business Overview
 Table 137. Mayer Laboratories, Inc. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Mayer Laboratories, Inc. Hormonal Contraception Product
 Table 139. Mayer Laboratories, Inc. Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Hormonal Contraception Distributors List
 Table 143. Hormonal Contraception Customers List
 Table 144. Hormonal Contraception Market Trends
 Table 145. Hormonal Contraception Market Drivers
 Table 146. Hormonal Contraception Market Challenges
 Table 147. Hormonal Contraception Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hormonal Contraception
 Figure 2. Global Hormonal Contraception Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hormonal Contraception Market Share by Type: 2024 & 2031
 Figure 4. by Hormone Product Picture
 Figure 5. by Method Product Picture
 Figure 6. Global Hormonal Contraception Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Hormonal Contraception Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinics
 Figure 10. Gynaecology Centers
 Figure 11. Others
 Figure 12. Global Hormonal Contraception Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Hormonal Contraception Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Hormonal Contraception Sales (2020-2031) & (K Units)
 Figure 15. Global Hormonal Contraception Average Price (US$/Unit) & (2020-2031)
 Figure 16. Hormonal Contraception Report Years Considered
 Figure 17. Hormonal Contraception Sales Share by Manufacturers in 2024
 Figure 18. Global Hormonal Contraception Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Hormonal Contraception Players: Market Share by Revenue in Hormonal Contraception in 2024
 Figure 20. Hormonal Contraception Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Hormonal Contraception Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Hormonal Contraception Sales Market Share by Country (2020-2031)
 Figure 23. North America Hormonal Contraception Revenue Market Share by Country (2020-2031)
 Figure 24. United States Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Hormonal Contraception Sales Market Share by Country (2020-2031)
 Figure 27. Europe Hormonal Contraception Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Hormonal Contraception Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Hormonal Contraception Revenue Market Share by Region (2020-2031)
 Figure 35. China Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Hormonal Contraception Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Hormonal Contraception Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Hormonal Contraception Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Hormonal Contraception Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Hormonal Contraception Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Hormonal Contraception by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Hormonal Contraception by Type (2020-2031)
 Figure 56. Global Hormonal Contraception Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Hormonal Contraception by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Hormonal Contraception by Application (2020-2031)
 Figure 59. Global Hormonal Contraception Price (US$/Unit) by Application (2020-2031)
 Figure 60. Hormonal Contraception Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Hormonal Contraceptive Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Contraceptives Drugs Market Insights Forecast to 2030
Global Contraceptives Devices Market Insights Forecast to 2030
Global Female Contraceptive Market Research Report 2024
Global Oral Contraceptive Drugs Market Insights Forecast to 2030
Global Levonorgestrel API Market Research Report 2024
Contraceptive Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hormonal Implants Market Insights Forecast to 2030
Global Combined Hormonal Contraceptive Market Research Report 2024
Global Long acting and Short acting Oral Contraceptives Market Research Report 2025
Global Levonorgestre Tablet Market Research Report 2025
Global Levonorgestre Capsule Market Research Report 2025
Global Hormones Contraceptive Patch Market Research Report 2024
Contraceptive Implants Market
Global Hormonal Supplements Market Research Report 2024
Global Hormonal Drugs Market Research Report 2025
Contraceptive Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Contraceptive Devices Market Research Report 2024
Global Emergency Contraceptive Pills Market Research Report 2024
Combined Oral Contraceptive Pill Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z19487
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34B2983
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19V3238
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35F5845
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions